Future proofed. Over the next few years, Cologne intends to further expand its position as a leading science city. By 2030, it will have invested more than 100 million euros in the Biocampus Cologne (BCC) project. The BCC is already one of the largest technology parks in Germany and, on some 25 hectares, offers an ideal environment for innovative technology companies.
Monrol, a Turkish biotech and world leader in nuclear medicine, is relocating to Cologne's Immendorf industrial park where it is establishing a center of excellence for radiopharmaceutical production. The new site, at which more than 100 staff will develop cancer therapy products, is being funded to the tune of 30 million euros.
As a science center, Cologne is being transformed into a showcase region. Home to the CoRe-Net research and development network for improving medical and social care in Germany, the Cathedral City is one of the few centers selected by the German Federal Ministry of Education and Research (BMBF) for this unprecedented level of structural funding.
Cologne’s dynamism and collaborative spirit is also evident when it comes to teaching and science. In partnership with HHU Düsseldorf, TH Köln university is developing a 3D printing process for patient-specific drugs. The novel process helps to improve the efficacy of the drugs and minimize their side effects
